Financhill
Back

Amedisys Quote, Financials, Valuation and Earnings

Amedisys Price Quote

$90.23
-0.26 (-0.29%)
(Updated: November 14, 2024 at 5:55 PM ET)

Amedisys Key Stats

Buy
53
Amedisys (AMED) is a Buy

Day range:
$89.83 - $91.90
52-week range:
$89.55 - $98.95
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.29
P/B ratio:
2.6%

Volume:
931.5K
Avg. volume:
507.7K
1-year change:
-3.31%
Market cap:
$3B
Revenue:
$2.2B
EPS:
$2.52

How Much Does Amedisys Make?

  • How Much Are Amedisys's Sales Annually?
    AMED Revenues are $2.2B
  • How Much Profit Does Amedisys's Make A Year?
    AMED net income is -$9.7M

Is Amedisys Growing As A Company?

  • What Is Amedisys's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.06%
  • What Is Amedisys's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.35%

Amedisys Stock Price Performance

  • Did Amedisys Stock Go Up Last Month?
    Amedisys share price went down by -6.06% last month
  • Did AMED's Share Price Rise Over The Last Year?
    AMED share price fell by -3.31% over the past 1 year

What Is Amedisys 52-Week High & Low?

  • What Is Amedisys’s 52-Week High Share Price?
    Amedisys has traded as high as $98.95 over the past 52 weeks
  • What Is Amedisys’s 52-Week Low Share Price?
    Amedisys has traded as low as $89.55 over the past 52 weeks

Amedisys Price To Free Cash Flow

  • Is Amedisys Stock Overvalued?
    Amedisys is trading at a price to free cash flow ratio of 14.73
  • Is Amedisys Stock Undervalued?
    Amedisys EV to Free Cash Flow ratio is 15.57
  • What Is Amedisys’s Price Earnings Growth Ratio?
    AMED PEG ratio is 0.01
  • Is Amedisys Trading At A Premium To Earnings?
    Amedisys EV to EBIT ratio is 19.02

Is It Risky To Buy Amedisys?

  • How Much Debt Does Amedisys Have?
    Total long term debt quarterly is $381.9M
  • How Much Cash Does Amedisys Have?
    Cash and short term investments quarterly total is $245.5M
  • What Is Amedisys’s Book Value Per Share?
    Book value per share is 35.05

Is Amedisys Cash Flow Positive?

  • What Is AMED Cash Flow From Operations?
    Cash flow from operations (TTM) is $211.7M
  • What Is Amedisys’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$51.1M
  • What Is Amedisys’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$9.1M

Amedisys Return On Invested Capital

  • Is Management Doing A Good Job?
    AMED return on invested capital is 5.39%
  • What Is Amedisys Return On Assets?
    ROA measures how assets are converting to revenues and is 3.97%
  • What Is AMED Return On Equity?
    ROE is a measure of profitability and is 7.23%

Amedisys Earnings Date & Stock Price

  • What Is Amedisys's Stock Price Today?
    A single share of AMED can be purchased today for 90.49
  • What Is Amedisys’s Stock Symbol?
    Amedisys trades on the nasdaq under the ticker symbol: AMED
  • When Is Amedisys’s Next Earnings Date?
    The next quarterly earnings date for Amedisys is scheduled on February 21, 2025
  • When Is AMED's next ex-dividend date?
    Amedisys's next ex-dividend date is November 15, 2024
  • How To Buy Amedisys Stock?
    You can buy Amedisys shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Amedisys Competitors

  • Who Are Amedisys's Competitors?
    Below is a list of companies who compete with Amedisys or are related in some way:
    • Addus HomeCare Corp (ADUS)
    • Chemed Corp (CHE)
    • Option Care Health Inc (OPCH)
    • OptimizeRx Corp (OPRX)
    • Regional Health Properties Inc (RHE)

Amedisys Dividend Yield

  • What Is AMED Dividend Yield?
    Amedisys’s dividend yield currently is 0%
  • What Is Amedisys’s Payout Ratio?
    Amedisys’s payout ratio is 0%
  • When Did Amedisys Last Pay A Dividend?
    The latest dividend pay date is November 15, 2024
  • What Is Amedisys’s Dividend Per Share?
    Amedisys pays a dividend of $0.00 per share

Amedisys Analyst Estimates

YoY Growth Past Surprise
EPS: -35.44% -14.33%
Revenue: 5.65% -0.19%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 8
Sell Recommendations: 1
Price Target: 96.33
Upside from Last Price: 6.46%

Major Shareholders

  • How many AMED shares are owned by institutional investors?
    41.8M AMED shares are owned by institutional investors
  • How many AMED shares are owned by insiders?
    3.3M AMED shares are owned by insiders